EUVIMEDEUVIMED entdecken
Systematische ÜbersichtVergleichsstudieOpen Access

Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema

Maureen Watt iD, Rachel Goldgrub iD, Mia Malmenäs iD, Katrin Haeussler

Journal of Comparative Effectiveness Research · 2025

DOI: 10.57264/cer-2024-0110 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Comparative Effectiveness Research, 2025. Verfasst von Maureen Watt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Takeda Development Center Americas, Inc., Lexington, MA 02421, USA. Hauptthemen laut MEDLINE: Angioedemas, Hereditary, Complement C1 Inhibitor Protein, Antibodies, Monoclonal, Humanized. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim: To compare the efficacy and safety of lanadelumab versus other approved long-term prophylaxis (LTP) treatments in patients with pediatric hereditary angioedema (HAE) aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioedemas, HereditaryComplement C1 Inhibitor ProteinAntibodies, Monoclonal, HumanizedHumansChildMaleTreatment OutcomeFemale

Stichwörter der Autor:innen

C1 esterase inhibitorcomparative effectivenesshereditary angioedemaindirect treatment comparisonlanadelumabprophylaxis

Substanzen

lanadelumabComplement C1 Inhibitor ProteinAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Takeda Development Center Americas, Inc., Lexington, MA 02421, USA.
  • ICON plc, Insights, Evidence & Value - Health Economics & Epidemiology, Vancouver, British Columbia, Canada.
  • ICON plc, Insights, Evidence & Value - Health Economics & Epidemiology, Stockholm, Sweden.
  • ICON plc, Insights, Evidence & Value - Health Economics & Epidemiology, Langen, Germany.

ORCID-Profile: Maureen Watt, Rachel Goldgrub, Mia Malmenäs

Zitieren

APA

Watt, M., Goldgrub, R., Malmenäs, M., & Haeussler, K. (2025). Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2024-0110

Vancouver

Watt M, Goldgrub R, Malmenäs M, Haeussler K. Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema. Journal of Comparative Effectiveness Research. 2025. doi:10.57264/cer-2024-0110

BibTeX
@article{Watt2025,
  author = {Watt, Maureen and Goldgrub, Rachel and Malmenäs, Mia and Haeussler, Katrin},
  title = {Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2025},
  doi = {10.57264/cer-2024-0110}
}
Kostenlos starten →